A Catalyst Filled Quarter Lies Around The Corner

My wife and I spent Good Friday in the car, driving up to Massachusetts to visit my number one newsletter fan; my mother. It...

LEXAGENE PROVIDES CORPORATE UPDATE

TW's Take: while disappointed in the stretched timeline for EUA approval, this is a very positive update. The vet market is sufficiently large to...

LEXAGENE RECEIVES $3.6M FROM THE EXERCISE OF WARRANTS

TW's Take: positive news for LexaGene putting more cash on the balance sheet as the company moves ever closer to their EUA filing. BEVERLY, Mass.,...

Heard On The Street

When I started in this business in the 1980s, "Heard on the Street" was a market moving column in the Wall Street Journal. R....

LexaGene Announces Change in Management and Appoints New Member to the Board of Directors

TW's Take: this is really a non-event for LexaGene, in terms of the business, however it is nice to get someone with a very...

LEXAGENE’S MIQLAB SUCCESSFULLY DETECTS MUTANT UK AND SOUTH AFRICAN COVID-19 SEQUENCES

TW's Take: while they will not incorporate these tests into their EUA application, LexaGene will be able to roll out additional tests broadly post...

The GameStop Impact…January In Review

What a crazy way to end a wild month, huh? As GameStop (GME) continued to rally in the face of shorts, Robin Hood required...

LEXAGENE INITIATES PROGRAM TO IDENTIFY UK AND SOUTH AFRICAN COVID SEQUENCES

TW's Take: the ability to rapidly diagnose different strains of Covid is a strength of LexaGene's open source system and a key differentiator versus...

LEXAGENE STARTS FDA EUA STUDY FOR POINT-OF-CARE COVID-19 TESTING

Tailwinds' Take: LexaGene is executing on their path to becoming a very disruptive force in the point-of-care diagnostics space. BEVERLY, Mass., Dec. 30, 2020 (GLOBE...

LexaGene to Place MiQLab Systems at Two Leading Specialty and Emergency Veterinary Care Hospitals

TW's Take: adoption is continuing. With an expected EUA application in early 2021, LexaGene is poised to disrupt the point-of-care diagnostics industry. BEVERLY, Mass. USA...

LexaGene Receives Purchase Order for MiQLab from Ethos Discovery

Tailwinds' Take: Positive news as products are shipping while we approach the pivotal EUA application coming soon. BEVERLY, Mass., Dec. 15, 2020 (GLOBE NEWSWIRE) -- LexaGene...

The Micro-Cap Rally Continues Full Force

November was truly a month to remember for the markets. The best month in over 40 years for the Russell 2000 saw that index...

A Micro Thanksgiving

Thanksgiving is usually a time to gather with friends and family to celebrate life. My favorite holiday of the year, it was always a...

LEXAGENE PLACES MIQLAB SYSTEM AT THE UNIVERSITY OF PENNSYLVANIA’S SCHOOL OF VETERINARY MEDICINE

Tailwinds' Take: We expect to see continued ramp-up of installations now that manufacturing has been ironed out and product is rolling out to the...

LEXAGENE RECEIVES PURCHASE ORDER FROM A MULTINATIONAL BIOTECHNOLOGY COMPANY

Tailwinds' Take: this is exciting news as the LexaGene PCR test is receiving customer approval prior to the official launch. The platform is very...

Time for Small Cap to Shine?

Small and micro-cap stocks have underperformed the market for quite a while now. Since I started Tailwinds in August of 2016, the Russell 2000...

LexaGene Provides a Corporate Update

Tailwinds' Take: LexaGene is approaching the finish line for bringing their technology to market. Delays in EUA approval are not uncommon and we remain...

The Final Push…

Like the debate, 2020 has been a sh**-show. Pandemics, political divisiveness, fires...it's not been a beach party to say the least. Yet, here we stand...

LexaGene’s CEO Provides Video Message on Company’s Progress and Announces Appointment of Dr. Shelley...

Tailwinds' Take: an excellent video update. LexaGene is on the cusp of FDA approval for Covid and launching product sales. The product could be...

West Bound and Down

After fortuitously sheltering in place on the east coast for seven weeks, we are heading back for CA this week. We seem to have,...

LexaGene’s Covid-19 Diagnostic Readies For The FDA

As we near the election, one thing that upon which both democrats and republicans seem to agree is that testing for Covid-19 has been...
DFC Advisory Services LLC (dba TW Research Group) is an investment adviser. We are also compensated for publishing information on certain companies. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance.